ENTO

Entero Therapeutics

10 hedge funds and large institutions have $47.6K invested in Entero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Geode Capital Management
1
Geode Capital Management
Massachusetts
$14.6K 36,560
UBS Group
2
UBS Group
Switzerland
$8.22K 20,553 -37,422 -65%
TSS
3
Two Sigma Securities
New York
$6.31K 15,776 +15,776 New
Jane Street
4
Jane Street
New York
$5.09K 12,730 +12,730 New
Renaissance Technologies
5
Renaissance Technologies
New York
$5K 12,500 +12,500 New
Citadel Advisors
6
Citadel Advisors
Florida
$4.97K 12,415 +12,415 New
TRCT
7
Tower Research Capital (TRC)
New York
$2.03K 5,064 -6 -0.1%
SS
8
SBI Securities
Japan
$1.32K 3,307
Bank of America
9
Bank of America
North Carolina
$17 42 +2 +5%
HF
10
HRT Financial
New York
-28,602 Closed
JC
11
JB Capital
Connecticut
-10,000 Closed
US Bancorp
12
US Bancorp
Minnesota
$0 1